News & Articles

AMSBIO announces the launch of a new range of circulating tumor DNA (ctDNA) reference standards for cancer disease management research

AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications

ScreenIn3D to offer platforms for personalized cancer treatment

AMSBIO’s new cell culture medium offers better conditions for induced pluripotent and embryonic stem cells, study shows

Global provider of gene editing and personalized medicine technologies has launched a service for high-throughput gene expression analysis

AMSBIO release a new medium for cryopreservation

AMSBIO announces new range of CD47-relevant products suitable for rapid high-throughput screening studies

AMSBIO sponsor organoid technology training course

AMSBIO has announced the availability of StemFit Basic02 feeder-free stem cell culture media

New range of recombinant antigens and antibodies suited for the development of rapid assays and overcoming the problem of cross-reactivity with related viruses